Neuroacanthocytosis: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
| name = Neuroacanthocytosis | |||
| image = [[File:Acanthocytosis.jpg|250px]] | |||
| caption = Blood smear showing acanthocytes | |||
| field = [[Neurology]], [[Hematology]] | |||
| symptoms = [[Movement disorders]], [[Chorea]], [[Dystonia]], [[Seizures]], [[Cognitive decline]] | |||
| onset = Typically in adulthood | |||
| duration = Chronic | |||
| causes = Genetic mutations (e.g., [[VPS13A]], [[KCTD17]]) | |||
| risks = Family history of neuroacanthocytosis | |||
| diagnosis = [[Genetic testing]], [[Blood smear]] | |||
| differential = [[Huntington's disease]], [[Wilson's disease]], [[Parkinson's disease]] | |||
| treatment = Symptomatic management, [[Physical therapy]], [[Speech therapy]] | |||
| prognosis = Progressive, variable | |||
| frequency = Rare | |||
}} | |||
{{Short description|A group of rare genetic disorders affecting the nervous system and red blood cells}} | {{Short description|A group of rare genetic disorders affecting the nervous system and red blood cells}} | ||
'''Neuroacanthocytosis''' refers to a group of rare genetic disorders characterized by the presence of [[acanthocytes]] in the blood and neurological symptoms. These disorders are typically progressive and can affect various systems in the body, particularly the [[nervous system]]. | '''Neuroacanthocytosis''' refers to a group of rare genetic disorders characterized by the presence of [[acanthocytes]] in the blood and neurological symptoms. These disorders are typically progressive and can affect various systems in the body, particularly the [[nervous system]]. | ||
==Overview== | ==Overview== | ||
Neuroacanthocytosis syndromes are a collection of disorders that share common features, including movement disorders, cognitive decline, and psychiatric symptoms. The presence of acanthocytes, which are spiculated red blood cells, is a hallmark of these conditions. The disorders are genetically heterogeneous, meaning they can be caused by mutations in different genes. | Neuroacanthocytosis syndromes are a collection of disorders that share common features, including movement disorders, cognitive decline, and psychiatric symptoms. The presence of acanthocytes, which are spiculated red blood cells, is a hallmark of these conditions. The disorders are genetically heterogeneous, meaning they can be caused by mutations in different genes. | ||
==Types of Neuroacanthocytosis== | ==Types of Neuroacanthocytosis== | ||
There are several types of neuroacanthocytosis, each with distinct genetic causes and clinical features: | There are several types of neuroacanthocytosis, each with distinct genetic causes and clinical features: | ||
===Chorea-acanthocytosis=== | ===Chorea-acanthocytosis=== | ||
Chorea-acanthocytosis is an autosomal recessive disorder caused by mutations in the [[VPS13A]] gene. It is characterized by chorea, which is a type of involuntary movement, as well as cognitive and behavioral changes. Patients may also experience [[seizures]] and [[myopathy]]. | Chorea-acanthocytosis is an autosomal recessive disorder caused by mutations in the [[VPS13A]] gene. It is characterized by chorea, which is a type of involuntary movement, as well as cognitive and behavioral changes. Patients may also experience [[seizures]] and [[myopathy]]. | ||
===McLeod syndrome=== | ===McLeod syndrome=== | ||
[[McLeod syndrome]] is an X-linked recessive disorder associated with mutations in the [[XK]] gene. It is characterized by movement disorders, peripheral neuropathy, and [[cardiomyopathy]]. Acanthocytes are present in the blood, and affected individuals may also have elevated levels of [[creatine kinase]]. | [[McLeod syndrome]] is an X-linked recessive disorder associated with mutations in the [[XK]] gene. It is characterized by movement disorders, peripheral neuropathy, and [[cardiomyopathy]]. Acanthocytes are present in the blood, and affected individuals may also have elevated levels of [[creatine kinase]]. | ||
===Pantothenate kinase-associated neurodegeneration=== | ===Pantothenate kinase-associated neurodegeneration=== | ||
[[Pantothenate kinase-associated neurodegeneration]] (PKAN) is caused by mutations in the [[PANK2]] gene. It is characterized by progressive dystonia, parkinsonism, and iron accumulation in the brain. Although acanthocytes may be present, they are not as prominent as in other neuroacanthocytosis syndromes. | [[Pantothenate kinase-associated neurodegeneration]] (PKAN) is caused by mutations in the [[PANK2]] gene. It is characterized by progressive dystonia, parkinsonism, and iron accumulation in the brain. Although acanthocytes may be present, they are not as prominent as in other neuroacanthocytosis syndromes. | ||
===Other forms=== | ===Other forms=== | ||
Other forms of neuroacanthocytosis include [[Huntington's disease-like 2]] and [[aceruloplasminemia]], which have overlapping features with the aforementioned disorders but are caused by different genetic mutations. | Other forms of neuroacanthocytosis include [[Huntington's disease-like 2]] and [[aceruloplasminemia]], which have overlapping features with the aforementioned disorders but are caused by different genetic mutations. | ||
==Symptoms== | ==Symptoms== | ||
The symptoms of neuroacanthocytosis can vary widely depending on the specific disorder but often include: | The symptoms of neuroacanthocytosis can vary widely depending on the specific disorder but often include: | ||
| Line 30: | Line 37: | ||
* Seizures | * Seizures | ||
* Muscle weakness and atrophy | * Muscle weakness and atrophy | ||
==Diagnosis== | ==Diagnosis== | ||
Diagnosis of neuroacanthocytosis involves a combination of clinical evaluation, blood tests to detect acanthocytes, and genetic testing to identify specific mutations. [[Magnetic resonance imaging]] (MRI) of the brain may also be used to assess structural changes. | Diagnosis of neuroacanthocytosis involves a combination of clinical evaluation, blood tests to detect acanthocytes, and genetic testing to identify specific mutations. [[Magnetic resonance imaging]] (MRI) of the brain may also be used to assess structural changes. | ||
==Treatment== | ==Treatment== | ||
There is currently no cure for neuroacanthocytosis, and treatment is primarily supportive and symptomatic. Management may include: | There is currently no cure for neuroacanthocytosis, and treatment is primarily supportive and symptomatic. Management may include: | ||
| Line 40: | Line 45: | ||
* Occupational therapy to assist with daily activities | * Occupational therapy to assist with daily activities | ||
* Genetic counseling for affected families | * Genetic counseling for affected families | ||
==Prognosis== | ==Prognosis== | ||
The prognosis for individuals with neuroacanthocytosis varies depending on the specific disorder and its severity. These conditions are generally progressive, leading to increasing disability over time. | The prognosis for individuals with neuroacanthocytosis varies depending on the specific disorder and its severity. These conditions are generally progressive, leading to increasing disability over time. | ||
==See also== | |||
== | |||
* [[Acanthocyte]] | * [[Acanthocyte]] | ||
* [[Movement disorder]] | * [[Movement disorder]] | ||
* [[Genetic disorder]] | * [[Genetic disorder]] | ||
* [[Neurology]] | * [[Neurology]] | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Neurological disorders]] | [[Category:Neurological disorders]] | ||
Latest revision as of 07:18, 6 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Neuroacanthocytosis | |
|---|---|
| |
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Movement disorders, Chorea, Dystonia, Seizures, Cognitive decline |
| Complications | N/A |
| Onset | Typically in adulthood |
| Duration | Chronic |
| Types | N/A |
| Causes | Genetic mutations (e.g., VPS13A, KCTD17) |
| Risks | Family history of neuroacanthocytosis |
| Diagnosis | Genetic testing, Blood smear |
| Differential diagnosis | Huntington's disease, Wilson's disease, Parkinson's disease |
| Prevention | N/A |
| Treatment | Symptomatic management, Physical therapy, Speech therapy |
| Medication | N/A |
| Prognosis | Progressive, variable |
| Frequency | Rare |
| Deaths | N/A |
A group of rare genetic disorders affecting the nervous system and red blood cells
Neuroacanthocytosis refers to a group of rare genetic disorders characterized by the presence of acanthocytes in the blood and neurological symptoms. These disorders are typically progressive and can affect various systems in the body, particularly the nervous system.
Overview[edit]
Neuroacanthocytosis syndromes are a collection of disorders that share common features, including movement disorders, cognitive decline, and psychiatric symptoms. The presence of acanthocytes, which are spiculated red blood cells, is a hallmark of these conditions. The disorders are genetically heterogeneous, meaning they can be caused by mutations in different genes.
Types of Neuroacanthocytosis[edit]
There are several types of neuroacanthocytosis, each with distinct genetic causes and clinical features:
Chorea-acanthocytosis[edit]
Chorea-acanthocytosis is an autosomal recessive disorder caused by mutations in the VPS13A gene. It is characterized by chorea, which is a type of involuntary movement, as well as cognitive and behavioral changes. Patients may also experience seizures and myopathy.
McLeod syndrome[edit]
McLeod syndrome is an X-linked recessive disorder associated with mutations in the XK gene. It is characterized by movement disorders, peripheral neuropathy, and cardiomyopathy. Acanthocytes are present in the blood, and affected individuals may also have elevated levels of creatine kinase.
Pantothenate kinase-associated neurodegeneration[edit]
Pantothenate kinase-associated neurodegeneration (PKAN) is caused by mutations in the PANK2 gene. It is characterized by progressive dystonia, parkinsonism, and iron accumulation in the brain. Although acanthocytes may be present, they are not as prominent as in other neuroacanthocytosis syndromes.
Other forms[edit]
Other forms of neuroacanthocytosis include Huntington's disease-like 2 and aceruloplasminemia, which have overlapping features with the aforementioned disorders but are caused by different genetic mutations.
Symptoms[edit]
The symptoms of neuroacanthocytosis can vary widely depending on the specific disorder but often include:
- Movement disorders such as chorea, dystonia, and parkinsonism
- Cognitive decline and dementia
- Psychiatric symptoms such as depression and psychosis
- Seizures
- Muscle weakness and atrophy
Diagnosis[edit]
Diagnosis of neuroacanthocytosis involves a combination of clinical evaluation, blood tests to detect acanthocytes, and genetic testing to identify specific mutations. Magnetic resonance imaging (MRI) of the brain may also be used to assess structural changes.
Treatment[edit]
There is currently no cure for neuroacanthocytosis, and treatment is primarily supportive and symptomatic. Management may include:
- Medications to control movement disorders and psychiatric symptoms
- Physical therapy to maintain mobility
- Occupational therapy to assist with daily activities
- Genetic counseling for affected families
Prognosis[edit]
The prognosis for individuals with neuroacanthocytosis varies depending on the specific disorder and its severity. These conditions are generally progressive, leading to increasing disability over time.
